Mark Neumann
Corporate Officer/Principal en INTRA-CELLULAR THERAPIES, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Mark Neumann is currently the Chief Commercial Officer & Executive VP at Intra-Cellular Therapies, Inc. Prior to his current position, he served as the Vice President-Global Marketing at Amgen, Inc. from 2016 to 2018.
Before that, he held the position of Vice President-Global Commercialization at Bristol Myers Squibb Co. from 2008 to 2014.
Mr. Neumann completed his undergraduate degree at Lafayette College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/03/2024 | 29 700 ( 0.03% ) | 2 M $ | 31/03/2024 |
Cargos activos de Mark Neumann
| Empresas | Cargo | Inicio |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Corporate Officer/Principal | 16/10/2018 |
Antiguos cargos conocidos de Mark Neumann.
| Empresas | Cargo | Fin |
|---|---|---|
| AMGEN INC. | Sales & Marketing | 01/09/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/05/2014 |
Formación de Mark Neumann.
| Lafayette College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Neumann
